Cohen Veterans Bioscience joins PRISM 2 consortium

Press/Media: ResearchProfessional

Description

Brain research and advocacy non-profit Cohen Veterans Bioscience (CVB) announced today that it joined the PRISM 2 consortium as as a designated associated partner of the Innovative Medicines Initiative (IMI).

Period23-Jun-2021 → 24-Jun-2021

Media coverage

101

Media coverage